Investor List:

Top Medical Devices Series A Investors in Canada (22)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Medical Devices investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Kunal Sethi, General Partner at Prithvi Ventures
Kunal Sethi
Prithvi Ventures·General Partner
Sweet spot: $1M
Range: $400K - $9.5M
Investors in Singapore, Investors in United Kingdom, Investors in Melbourne (Australia), Investors in Canada, Investors in United States, Investors in Europe
Investors in AgTech (Series A), Investors in AgTech (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Seed), Investors in EnergyTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in AgTech (Seed), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in BioTech (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in ClimateTech/CleanTech (Seed), Investors in EnergyTech (Seed), Investors in New York City (Other Lists), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in Canada (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Chemicals (Series A), Investors in Chemicals (Seed), Investors in Drug Delivery (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Chemicals (Seed), Investors in Chemicals (Series A), Investors in Medical Devices (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Series A)
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Medical Devices (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Hardware (Series B), Investors in Hardware (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Robotics (Series A), Investors in Robotics (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Investors who were founders (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Investors who invested in female founders (Other Lists), Investors in BioTech (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in Hardware (Seed), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Hardware (Series A), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Hardware (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Canada (Other Lists), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Digital Health (Series B), Investors in Hardware (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Hardware (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Robotics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Eric Rosenblum, Managing Partner at Foothill Ventures (formerly Tsingyuan Ventures)
Eric Rosenblum
Sweet spot: $1M
Range: $100K - $10.0M
Investors in United States, Investors in Canada
Investors in Material Science (Seed), Investors in Medical Devices (Seed), Investors in Developer Tools (Series A), Investors in Developer Tools (Seed), Investors in EnergyTech (Seed), Investors in EnergyTech (Series A), Investors in Medical Devices (Series A), Investors in Material Science (Series A), Investors in AI (Seed), Investors in Logistics (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Series A), Investors in Logistics (Series A), Investors in AI (Seed), Investors in Health IT (Series A), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in AI (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in Developer Tools (Seed), Investors in Enterprise (Seed), Investors in EnergyTech (Seed), Investors in Enterprise (Series A), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in SaaS (Seed), Investors in Material Science (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Manufacturing (Seed), Investors in Logistics (Seed), Investors in AI (Series A), Investors in Developer Tools (Series A), Investors in EnergyTech (Series A), Investors in Enterprise (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in SaaS (Series A), Investors in Material Science (Series A), Investors in Manufacturing (Series A), Investors in Logistics (Series A), Investors in Canada (Other Lists), Investors in EnergyTech (Pre-seed), Investors in Material Science (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in AI (Pre-seed), Investors in Developer Tools (Pre-seed), Investors in Logistics (Pre-seed), Investors in Health IT (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in AI (Pre-seed), Investors in Enterprise (Pre-seed), Investors in SaaS (Pre-seed), Investors in Enterprise (Pre-seed), Investors in Health IT (Pre-seed), Investors in SaaS (Pre-seed), Investors in Developer Tools (Pre-seed), Investors in Material Science (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Logistics (Pre-seed), Investors in SaaS (Series A), Investors in Health IT (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed)
Photo of Geron Vanderfeesten, Managing Director at VDF Ventures
Geron Vanderfeesten
VDF Ventures·Managing Director
Sweet spot: $2.0M
Range: $500K - $15.0M
Investors in Middle East, Investors in Europe, Investors in Canada, Investors in United States
Investors in AgTech (Series B), Investors in Web3/Blockchain (Series B), Investors in Medical Devices (Seed), Investors in AgTech (Series A), Investors in AI (Series B), Investors in Payments (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in AgTech (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in Payments (Series B), Investors in ClimateTech/CleanTech (Seed), Investors in Web3/Blockchain (Seed), Investors in Medical Devices (Series B), Investors in Payments (Series A), Investors in Enterprise (Series B), Investors in Web3/Blockchain (Series A), Investors in Medical Devices (Series A), Investors in FinTech (Series B), Investors in AI (Seed), Investors in AgTech (Seed), Investors in AI (Seed), Investors in AI (Series A), Investors in SaaS (Series B), Investors in Web3/Blockchain (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Enterprise (Seed), Investors in Enterprise (Series A), Investors in FinTech (Seed), Investors in Medical Devices (Seed), Investors in Payments (Seed), Investors in SaaS (Seed), Investors in AI (Series A), Investors in AgTech (Series A), Investors in Web3/Blockchain (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in FinTech (Series A), Investors in Enterprise (Series A), Investors in Medical Devices (Series A), Investors in Payments (Series A), Investors in SaaS (Series A), Investors in AI (Series B), Investors in AgTech (Series B), Investors in Web3/Blockchain (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Enterprise (Series B), Investors in FinTech (Series B), Investors in Medical Devices (Series B), Investors in Payments (Series B), Investors in SaaS (Series B), Investors in Canada (Other Lists), Investors in Cybersecurity (Seed), Investors in Cybersecurity (Series A), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Cybersecurity (Series B), Investors in Cybersecurity (Series B), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Seed), Investors in SaaS (Series A), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed)
Photo of Xinhong Lim, Managing Director at Vickers Venture Partners
Xinhong Lim
Vickers Venture Partners·Managing Director
Sweet spot: $5.0M
Range: $3.0M - $10.0M
Investors in Singapore, Investors in United Kingdom, Investors in United States, Investors in China, Investors in Indonesia, Investors in Canada
Investors in AI (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in EnergyTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in Material Science (Series A), Investors in Chemicals (Series A), Investors in Chemicals (Series B), Investors in BioTech (Series A), Investors in Semiconductors (Series A), Investors in Semiconductors (Series B), Investors in Pharmaceuticals (Series A), Investors in Diverse Investors (Other Lists), Investors in AI (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in AI (Series A), Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in Medical Devices (Series A), Investors in Semiconductors (Series A), Investors in Pharmaceuticals (Series A), Investors in Chemicals (Series A), Investors in AI (Series B), Investors in Material Science (Series A), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in EnergyTech (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Material Science (Series B), Investors in Semiconductors (Series B), Investors in Chemicals (Series B), Investors in Canada (Other Lists), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B)
Photo of Jean-François Pariseau, Partner at Amplitude VC
Jean-François Pariseau
Amplitude VC·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Canada, Investors in Montreal
Investors in Medical Devices (Seed), Investors in Impact (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in Impact (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in AI (Seed), Investors in Diverse Investors (Other Lists), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in AI (Seed), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in BioTech (Seed), Investors in AI (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in Impact (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Health IT (Series A), Investors in Impact (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Canada (Other Lists), Investors in Drug Delivery (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
Photo of Alexandre Nossovskoi, Principal at Esplanade HealthTech Ventures
Alexandre Nossovskoi
Sweet spot: $1.5M
Range: $500K - $5.0M
Investors in Canada, Investors in United States
Photo of Jason Robertson, General Partner at Nimbus Synergies
Jason Robertson
Nimbus Synergies·General Partner
Sweet spot: $1M
Range: $500K - $1.5M
Investors in Canada, Investors in British Columbia
Investors in Medical Devices (Series A), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Health IT (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in British Columbia (Other Lists), Investors in Canada (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Series A), Investors in Medical Devices (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in Health IT (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Digital Health (Series A)